IP Library › Granted Patent US 11,859,233
Granted Patent B2
US 11,859,233 · App. 17/681,899 · Granted Jan 2, 2024

Rapid microbial detection

Inventor: Rajesh Krishnamurthy (Germantown, MD)
Assignee: 3I DIAGNOSTICS, INC.
C12Q1/24C12Q1/04B01L3/50825B01L3/502753B01L2200/0647B01L2200/0684B01L2200/10B01L2200/141B01L2300/023B01L2300/044B01L2300/0681
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,859,233
App. No.
17/681,899
Granted
Jan 2, 2024
Kind
B2
Abstract

Devices and methods are provided to detect the presence of bacteria and small microorganisms, and to identify various microbial attributes rapidly.

Claims (25)

1. A detection system for identifying microorganisms within a sample, the sample comprising a fluid and including non-microbial cells and microorganisms, the detection system comprising:

a microfluidic separation stage comprising a lysis structure that includes an inlet, an outlet, and microporous surfaces disposed between the inlet and the outlet to receive the sample and selectively lyse non-microbial cells while maintaining intact microorganisms in the sample when the sample flows between the inlet and the outlet and through the microporous surfaces of the lysis structure;

a detection stage to receive the sample from the microfluidic separation stage and perform detection analysis of microorganisms in the sample.

2. The detection system of claim 1 , wherein the microorganisms are selected from the group consisting of bacteria, fungi, and small unicellular and multicellular organisms.

3. The detection system of claim 1 , wherein the sample is a liquid selected from the group consisting of whole blood, plasma, serum, saliva, urine, cerebrospinal fluid, water, and fruit and vegetable juices.

4. The detection system of claim 1 , wherein the sample is selected from the group consisting of a fluid derived from meat, produce, processed food, dairy products, poultry products, pharmaceutical process streams, bulk drug substance, and final drug product.

5. The detection system of claim 1 , wherein the volume of the sample ranges from about 0.1 mL to about 10 mL.

6. The detection system of claim 1 , wherein the microfluidic separation stage further comprises:

a first separation stage to separate components that are larger in size than the microorganisms for detection, wherein the lysis structure receives the sample from the first separation stage at the inlet of the lysis structure; and

a second separation stage to receive the sample from the outlet of the lysis structure, the second separation stage to separate lysed cells and cellular debris from the microorganisms for detection.

7. The detection system of claim 1 , wherein the microfluidic separation stage concentrates the microorganisms in the sample by a process selected from the group consisting of reduction in total sample volume and filtration.

8. The detection system of claim 1 , further comprising:

an identification stage to identify intact microorganisms based upon the detection analysis.

9. The detection system of claim 8 , wherein the identification stage further comprises a measurement stage that measures the signatures of the microorganisms in transmission mode.

10. The detection system of claim 9 , wherein the measurement stage further comprises a flow cell or detection window.

11. The detection system of claim 9 , wherein the measurement stage comprises polycrystalline silicon.

12. The detection system of claim 9 , wherein the identification stage further comprises a computer system.

13. The detection system of claim 9 , wherein the identification stage further comprises a reporting stage.

14. The detection system of claim 1 , further comprising a waste collection stage.

15. The detection system of claim 1 , further comprising a control stage.

16. The detection system of claim 1 , wherein the microorganisms are selected from the group of genera consisting of Staphylococcus, Escherichia, Listeria, Salmonella, Streptococcus, Klebsiella and Campylobacter.

17. The detection system of claim 1 , wherein the detection system is portable.

18. The detection system of claim 1 , wherein the microporous surfaces are sized to permit passage of intact microorganisms in the sample through the microporous surfaces while lysing non-microbial cells.

19. The detection system of claim 1 , wherein the microporous surfaces include pores having diameters from 1 micrometer to 10 micrometers.

20. The detection system of claim 1 , wherein the lysis structure comprises at least one porous monolithic structure disposed between the inlet and the outlet of the microfluidic separation stage, and the porous monolithic structure includes the microporous surfaces.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2022
From: KRISHNAMURTHY, RAJESH
To: 3I DIAGNOSTICS, INC.
Reel/Frame 059788/0771 →
Continuity (3)
Continuation 14893689
Provisional Application 61956065 · May 31, 2013
Related Publication 20220290207A1 · Sep 15, 2022